RE-MATCH PROTOCOL: PHASE I STUDY OF AUTOLOGOUS TUMOR SPECIFIC LYMPHOCYTE TRANSFER (ALT) plus DC VACCINE (DCV) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY (MAC) AND AUTOLOGOUS STEM CELL RESCUE (HDC plus ASCR) OR NON-MYELOABLATIVE CHEMOTHERAPY (NMAC) IN PATIENTS WITH RECURRENT CENTRAL PNETS (R-PNET)

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Gururangan, S; Grant, G; Driscoll, T; Archer, G; Herndon, J; Friedman, H; Kurtzberg, J; Bigner, D; Sampson, J; Mitchell, D

Published Date

  • June 1, 2018

Published In

Volume / Issue

  • 20 /

Start / End Page

  • 104 - 104

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1523-5866

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • 18th International Symposium on Pediatric Neuro-Oncology (ISPNO)

Conference Location

  • Denver, CO

Conference Start Date

  • June 30, 2018

Conference End Date

  • July 3, 2018